SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036806
Filing Date
2020-08-05
Accepted
2020-08-05 16:09:59
Documents
58
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fate-10q_20200630.htm   iXBRL 10-Q 2293937
2 EX-10.1 fate-ex101_201.htm EX-10.1 2002860
3 EX-10.2 fate-ex102_199.htm EX-10.2 240339
4 EX-10.3 fate-ex103_200.htm EX-10.3 191041
5 EX-31.1 fate-ex311_7.htm EX-31.1 9825
6 EX-32.1 fate-ex321_6.htm EX-32.1 4866
7 GRAPHIC ge2sj0uhtrcz000001.jpg GRAPHIC 4204
  Complete submission text file 0001564590-20-036806.txt   12210048

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA fate-20200630.xsd EX-101.SCH 51295
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fate-20200630_cal.xml EX-101.CAL 47866
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fate-20200630_def.xml EX-101.DEF 195314
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20200630_lab.xml EX-101.LAB 438692
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20200630_pre.xml EX-101.PRE 323217
13 EXTRACTED XBRL INSTANCE DOCUMENT fate-10q_20200630_htm.xml XML 2212850
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36076 | Film No.: 201077334
SIC: 2836 Biological Products, (No Diagnostic Substances)